TP53 and neoplasm: Despite a lack of histologic similarity and thus the usage of the term “basal-like” for BRCA, the consistent molecular features of TP53 mutation, 5q deletion, and hallmark signature changes of high proliferation and glycolysis signaling across these tumor types are clinically meaningful, with marked worsened prognosis in these tumors.